You are here: Industry Insights > stroke

News List

Brilinta Granted FDA Priority Review americanpharmaceuticalreview
July 21, 2020
AstraZeneca announced the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for Brilinta (ticagrelor) for the reduction of subsequent stroke in patients ...
Charity warns of 'catastrophic' effect of COVID-19 on stroke research pharmatimes
July 14, 2020
The Stroke Association says it has been forced to suspend three-quarters of its funded research projects because of the coronavirus pandemic, which has devastated its fund-raising capabilities.
FDA approves new indication for AstraZeneca’s heart disease drug Brilinta pharmaceutical-business-review
June 03, 2020
AstraZeneca has secured approval from the US Food and Drug Administration (FDA) for its Brilinta (ticagrelor) to minimise the risk of a first heart attack or stroke in high-risk patients with a heart disease known as coronary artery disease (CAD).
Risk of death by stroke down 24% pharmatimes
March 17, 2020
The National Institute for Health Research (NIHR) has revealed that the risk of death and disability after a stroke fell significantly between 2000 and 2015.
Exosomes promote remarkable recovery in stroke worldpharmanews
January 15, 2020
It's been almost a quarter century since the first drug was approved for stroke. But what's even more striking is that only a single drug remains approved today.
FDA approves first generics of Eliquis americanpharmaceuticalreview
December 24, 2019
The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients ...
Heart Risks in Your Genes? Be Sure to Get Your Zzzs drugs
December 19, 2019
Good sleep patterns can help reduce your risk of heart disease or stroke, even if you're at high genetic risk, new research shows.
TSI Reports Enrollment of First 10 Patients in its Phase 2 Ischemic Stroke Clinical Trial and Completion of its Phase 2 Study Protocol in Myocardial Infarction b3cnewswire
October 31, 2019
Thrombolytic Science, LLC (TSI) announced progress with 10 patients enrolled in its prospective, randomized, multicenter Phase 2 clinical trial, designed to confirm the safety and ...
New Research on Climate Change and the Brain, the Relationship Between Stroke and Dementia, Advances in Epilepsy and MS Among the Brain Health Initiatives Unveiled at 24th World Congress of Neurology En-CPhI.CN
October 23, 2019
Promising scientific research on the impact of climate change on brain health, advancements in epilepsy and multiple sclerosis, the relationship between stroke and dementia ...
Why Aren't More Stroke Survivors Getting Statins? drugs
September 27, 2019
People with a history of stroke are less likely than those with heart disease to get cholesterol-lowering statin drugs despite the benefits, a new study has found.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page